Dexmedetomidine enhances hypoxia-induced cancer cell progression

Dexmedetomidine (DEX) is widely used in perioperative settings for analgesia and sedation; however, little is known about its effects on the hypoxia-induced progression of tumor cells. In the present study, the effects of DEX on hypoxia-induced growth and metastasis of lung cancer cells and colorect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hua Yan, Li, Geng Hua, Tan, Guo Cheng, Liang, Hua, Lai, Xiao Hong, Huang, Qiong, Zhong, Ji Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861874/
https://www.ncbi.nlm.nih.gov/pubmed/31772647
http://dx.doi.org/10.3892/etm.2019.8136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861874/
https://www.ncbi.nlm.nih.gov/pubmed/31772647
http://dx.doi.org/10.3892/etm.2019.8136

Ejemplares similares